The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 15, 2019

Filed:

Oct. 25, 2016
Applicants:

Laboratoire Francais Du Fractionnement Des Biotechnologies, Les Ulis, FR;

Centre Regional DE Lutte Contre Le Cancer, Montpellier, FR;

I.n.s.e.r.m. (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;

Universite Montpellier 1, Montpellier, FR;

Inventors:

Christine Gaucher, Equedin, FR;

Isabelle Navarro-Teulon, Saint Gely du Fesc, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 45/06 (2006.01); A61K 33/24 (2006.01); A61K 9/00 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2869 (2013.01); A61K 9/0019 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 33/24 (2013.01); A61K 39/3955 (2013.01); A61K 39/39533 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/28 (2013.01); C07K 16/3069 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.


Find Patent Forward Citations

Loading…